Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Mr Aoyagi of JPMA Calls for Negotiating Invoice Prices for Individual Products
November 17, 2014
- No Nippon Pharmacy Association Affiliated Pharmacy Will Be Subject to Medical Fee Cut Rule: Survey
November 17, 2014
- JPMA, JPPA, and JPWA Express Strong Opposition to Annual NHI Price Revision
November 4, 2014
- EFPIA Japan Official Calls for More-Effective Use of Surplus Raw Plasma
October 30, 2014
- April-June Generic Share at 49.8% under New Formula: JGA
October 29, 2014
- JPMA to Launch Compound Library Joint Purchasing Initiative; Full-Scale Purchasing to Begin in FY2015
October 29, 2014
- FPMAJ Sets Up Panel to Discuss Selective Sales Tax Breaks
October 27, 2014
- Japan CRO Association Nearing Remote Verification Agreement with Cancer Treatment Center
October 22, 2014
- JPMA Tones Down Demand on R&D Tax Credit System, Calls for “Maintenance” Instead of “Perpetuation”
October 20, 2014
- JMA Pres. Frets Proposed Introduction of Reference Pricing Rule
October 17, 2014
- JPMA Decides on More Close-Up Disclosure for R&D Outlays
October 17, 2014
- Industry Associations Call for Delay in Ratification of COP10 Nagoya Protocol
October 10, 2014
- US Nonprofit ACRES Launches Japan Branch
October 8, 2014
- National University Hospital Council’s Guidelines Not to Require Disclosure of Individuals’ Names
October 7, 2014
- JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
- Bayer Yakuhin President to Become New EFPIA Japan Chairman
October 2, 2014
- JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
September 26, 2014
- JPMA to Unify Method of Disclosing Sensitive Payment Information from Next Year
September 22, 2014
- JPMA to Suspend Hasegawa’s Veep Activities for Another 6 Months over CASE-J
September 19, 2014
- CDISC CEO Advises Drug Makers to Collect Data Based on CDASH
August 27, 2014
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…